Ignite Creation Date:
2024-05-06 @ 5:50 PM
Last Modification Date:
2024-10-26 @ 2:36 PM
Study NCT ID:
NCT05448326
Status:
RECRUITING
Last Update Posted:
2024-03-20
First Post:
2022-06-01
Brief Title:
The Diagnostic Observatory Combating Diagnostic Wandering and Impasse Within the AnDDI-Rares Network
Sponsor:
Centre Hospitalier Universitaire Dijon
Organization:
Centre Hospitalier Universitaire Dijon
Study Overview
Official Title:
The Diagnostic Observatory Combating Diagnostic Wandering and Impasse Within the AnDDI-Rares Network
Status:
RECRUITING
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
Obs du Diag
Brief Summary:
The Direction Générale de lOrganisation des Soins DGOS and the Banque Nationale de Données Maladies Rares BNDMR have launched a call for a letter of commitment for the implementation of a diagnostic observatory in order to fight against diagnostic wandering and impasse In this context the AnDDI-Rares network proposes 3 work packages WP to respond to the missions entrusted to it
Work package 1 of the diagnostic observatory includes a retrospective and prospective study to evaluate how diagnostic wandering and impasse has evolved within the network with regard to the integration of new technologies and the expectations of patients and their families
Work package 2 of the diagnostic observatory includes a reassessment of sporadic copy number variations CNV of unknown significance of more than 1 Mb obtained since the beginning of CGH array analyses in the territory
Work package 3 of the diagnostic observatory aims to help put an end to diagnostic wandering for patients with certain emblematic syndromes by proposing genome and RNA analysis which provides a certain diagnosis and negative targeted molecular study
Work package 1 of the diagnostic observatory includes a retrospective and prospective study to evaluate how diagnostic wandering and impasse has evolved within the network with regard to the integration of new technologies and the expectations of patients and their families
Work package 2 of the diagnostic observatory includes a reassessment of sporadic copy number variations CNV of unknown significance of more than 1 Mb obtained since the beginning of CGH array analyses in the territory
Work package 3 of the diagnostic observatory aims to help put an end to diagnostic wandering for patients with certain emblematic syndromes by proposing genome and RNA analysis which provides a certain diagnosis and negative targeted molecular study
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None